Allscripts Finishes in Top 3 Across Multiple Product Categories – Emergency
Department, Discharge Management, Practice Management, Document Management,
Homecare and Electronic Healthcare Records
CHICAGO, Dec. 16 /PRNewswire-FirstCall/ — Allscripts today announced that
the company’s Enterprise (formerly TouchWorks(R)) Electronic Health Record
(EHR) was named the No. 1 product in its market segment for the second year in
a row by the prestigious research group, KLAS. In its closely watched 2008
Top 20 Best in KLAS Awards: Software & Professional Services report, KLAS also
recognized Allscripts Care Management as the “Category Leader” in the
Discharge Planning hospital market segment.
(Logo: http://www.newscom.com/cgi-bin/prnh/20081013/AQM041LOGO)
In addition to this recognition, several other Allscripts solutions –
Allscripts ED Emergency Department Information System, Allscripts Professional
EHR, Allscripts Document Management, Allscripts Homecare, and Allscripts
Practice Management – all placed in the Top Three in categories in which they
compete, according to the report released Dec. 15. KLAS rankings are generated
by in-depth interviews with thousands of actual end-users of the products
reviewed.
Allscripts Enterprise earned the “Best in KLAS” designation as the top
Electronic Health Record for practices with between 26 and 100 physicians.
Ninety-three percent of both Allscripts Enterprise and Allscripts Care
Management clients surveyed said they would buy the solutions again – higher
recommendations than respondents gave all other products in their respective
market segments.
“Our top placement in KLAS, the ‘Consumer Reports’ of healthcare I.T., is
confirmation from physician groups and hospitals that Allscripts continues to
lead the marketplace,” said Glen Tullman, Chief Executive Officer of
Allscripts. “We are particularly proud of our consistent performance across
all of our products because it confirms that we’re succeeding at what is most
important – delivering for our clients.”
KLAS is a research and consulting firm specializing in monitoring and
reporting the performance of healthcare information technology (HIT) vendors.
The firm’s Top 20 Best in KLAS Awards: Software & Professional Services report
provides its summary of HIT product and service performance data collected
over the past 13 months as reported by integrated delivery networks (IDNs),
physician groups and inpatient facilities. The KLAS database represents the
opinions of healthcare executives, managers, and clinicians from over 4,500
healthcare facilities on more than 300 vendors and over 500 different
products.
For more information on the 2008 Top 20 Best in KLAS Awards: Software &
Professional Services, visit KLAS on the Web at
http://www.klasresearch.com/top_20.
About Allscripts
Allscripts (NASDAQ: MDRX) uses innovation technology to bring health to
healthcare. More than 150,000 physicians, 700 hospitals and nearly 7,000 post-
acute and homecare organizations utilize Allscripts to improve the health of
their patients and their bottom line. The company’s award-winning solutions
include electronic health records, electronic prescribing, revenue cycle
management, practice management, document management, medication services,
hospital care management, emergency department information systems and
homecare automation. Allscripts is the brand name of Allscripts-Misys
Healthcare Solutions, Inc. To learn more, visit www.allscripts.com.
This news release may contain forward-looking statements within the
meaning of the federal securities laws. Statements regarding future events,
developments, the Company’s future performance, as well as management’s
expectations, beliefs, intentions, plans, estimates or projections relating to
the future are forward-looking statements within the meaning of these laws.
These forward-looking statements are subject to a number of risks and
uncertainties, some of which are outlined below. As a result, actual results
may vary materially from those anticipated by the forward-looking statements.
Among the important factors that could cause actual results to differ
materially from those indicated by such forward-looking statements are: the
volume and timing of systems sales and installations; length of sales cycles
and the installation process; the possibility that products will not achieve
or sustain market acceptance; the timing, cost and success or failure of new
product and service introductions, development and product upgrade releases;
competitive pressures including product offerings, pricing and promotional
activities; our ability to establish and maintain strategic relationships;
undetected errors or similar problems in our software products; compliance
with existing laws, regulations and industry initiatives and future changes in
laws or regulations in the healthcare industry; possible regulation of the
Company’s software by the U.S. Food and Drug Administration; the possibility
of product-related liabilities; our ability to attract and retain qualified
personnel; our ability to identify and complete acquisitions, manage our
growth and integrate acquisitions; the ability to recognize the benefits of
the merger with Misys Healthcare Systems, LLC (“MHS”); the integration of MHS
with the Company and the possible disruption of current plans and operations
as a result thereof; maintaining our intellectual property rights and
litigation involving intellectual property rights; risks related to third-
party suppliers; our ability to obtain, use or successfully integrate third-
party licensed technology; breach of our security by third parties; and the
risk factors detailed from time to time in our reports filed with the
Securities and Exchange Commission, including our 2007 Annual Report on Form
10-K available through the Web site maintained by the Securities and Exchange
Commission at www.sec.gov. The Company undertakes no obligation to update
publicly any forward-looking statement, whether as a result of new
information, future events or otherwise.
Available Topic Expert(s): For information on the listed expert(s), click
appropriate link.
Glen Tullman
https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=80768
SOURCE: Allscripts 12/16/2008
CONTACT: Dan Michelson, Chief Marketing Officer, +1-312-506-1217,
dan.michelson@allscripts.com
or
Todd Stein, Senior Manager|Public Relations,
+1-312-506-1216,
todd.stein@allscripts.com
both of Allscripts
(MDRX)